$99.0M in total Medicare payments across 5 years
Procedure 81518 (Mrna gene analysis of 11 genes in breast tumor tissue) received $99.0M in total Medicare payments.
Across 25.9K services, the average Medicare payment was $3.8K per service.
CA leads in spending on this procedure, accounting for 35% of all payments.
AI-generated analysis based on Medicare payment data.
| Year | Payments | Services | YoY Change |
|---|---|---|---|
| 2019 | $6.9M | 1.8K | — |
| 2020 | $8.7M | 2.3K | +25.7% |
| 2021 | $21.2M | 5.5K | +144.0% |
| 2022 | $27.9M | 7.3K | +31.8% |
| 2023 | $34.2M | 9.0K | +22.6% |
| # | Provider | Specialty | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|---|
| 1 | Biotheranostics, Inc. | Clinical Laboratory | CA | $34.2M | 9.0K | $3.8K |
| State | Payments | Services | Providers | Avg/Provider |
|---|---|---|---|---|
| CA | $34.2M | 9.0K | 1 | $34.2M |
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.